Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Biomaterials. 2010 Feb 13;31(14):4146–4156. doi: 10.1016/j.biomaterials.2010.01.112

Table 1.

Composition of microsphere-incorporating PMMA/CMC/PLGA constructs prior to fabrication and in dried samples

PMMA/CMC/PLGA constructs Initial composition Composition of dried sample

PLGA conc.
(wt%)
CMC conc.
(wt%)
PLGA conc.
(wt%)
CMC salt conc.
(wt%)
Drug content
(wt%) mg/mL scaffold
10%PLGA-40%CMC 10 40 9.4 5.7 1.5 11.2
15%PLGA-40%CMC 15 40 14.1 5.7 2.3 16.6
10%PLGA-50%CMC 10 50 9.2 8.3 1.5 9.1
15%PLGA-50%CMC 15 50 13.8 8.3 2.2 13.4